Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SC 13G/A Feb 11, 2022 AMENDMENT NO. 1 TO SCHEDULE 13G
SC 13G/A Feb 11, 2022 AMENDMENT NO. 1
SC 13G/A Feb 11, 2022 CHI ADVISORS LLC
4 Jan 20, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Jan 20, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
10-Q Nov 12, 2021 10-Q
8-K Nov 12, 2021 8-K
8-K Aug 12, 2021 8-K
10-Q Aug 12, 2021 10-Q
SC 13D/A Jul 2, 2021
4 Jul 2, 2021
4 Jul 2, 2021 PRIMARY DOCUMENT
8-K Jul 1, 2021 8-K
8-K Jun 14, 2021 8-K
SC 13D/A May 26, 2021
8-K May 26, 2021 8-K
SC 13D/A May 21, 2021
8-K May 21, 2021 8-K
8-K May 21, 2021 8-K
4 May 20, 2021 PRIMARY DOCUMENT
8-K May 18, 2021 8-K
4 May 17, 2021
4 May 17, 2021 PRIMARY DOCUMENT
4 May 17, 2021 PRIMARY DOCUMENT
4 May 17, 2021 PRIMARY DOCUMENT
← Newer Page 10 of 28 · 696 filings Older →